Latest & greatest articles for insomnia

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on insomnia or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on insomnia and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for insomnia

41. Relaxation Training for Insomnia

Relaxation Training for Insomnia Relaxation Training for Insomnia | Society of Clinical Psychology Relaxation Training for Insomnia Status: Strong Research Support Description In relaxation-based treatments, patients are taught formal exercises focused on reducing somatic tension (e.g., progressive muscle relaxation, autogenic training) or intrusive thoughts at bedtime (e.g., imagery training, meditation). Multiple weekly or biweekly sessions are typically required to adequately teach (...) relaxation skills. Practice at home is also encouraged, so patients can gain mastery of the relaxation techniques. Although relaxation therapy is demonstrably effective, there is little evidence suggesting differential effectiveness across the range of relaxation modalities. Key References (in reverse chronological order) Morin, C., Bootzin, R., Buysse, D., Edinger, J., Espie, C., & Lichstein, K. (2006). Psychological and behavioral treatment of insomnia: Update of the recent evidence (1998-2004). Sleep

Society of Clinical Psychology2014

42. Paradoxical Intention for Insomnia

Paradoxical Intention for Insomnia Paradoxical Intention for Insomnia | Society of Clinical Psychology Paradoxical Intention for Insomnia Status: Strong Research Support Description Paradoxical intention is a cognitive technique that consists of persuading a patient to engage in his or her most feared behavior. In the context of insomnia, this type of therapy is premised on the idea that performance anxiety inhibits sleep onset. Paradoxically, if a patient stops trying to fall asleep (...) ). Psychological and behavioral treatment of insomnia: Update of the recent evidence (1998-2004). Sleep , 29, 1398-1414. Broomfield, N.M., Espie, C.A. (2003). Initial insomnia and paradoxical intention: An experimental investigation of putative mechanisms using subjective and actigraphic measurement of sleep. Behavioural and Cognitive Psychotherapy, 31, 313-324. Morin, C.M., Hauri, P.J., Espie, C.A., Spielman, A.J., Buysse, D.J., & Bootzin, R.R. (1999). Nonpharmacologic treatment of chronic insomnia: An

Society of Clinical Psychology2014

43. Cognitive Behavioral Therapy for Insomnia

Cognitive Behavioral Therapy for Insomnia Cognitive Behavioral Therapy for Insomnia | Society of Clinical Psychology Problem Area: Treatment: Cognitive Behavioral Therapy for Insomnia : Treatment pending re-evaluation Very strong: High-quality evidence that treatment improves symptoms and functional outcomes at post-treatment and follow-up; little risk of harm; requires reasonable amount of resources; effective in non-research settings Strong: Moderate- to high-quality evidence that treatment (...) Insomnia. Brief Summary Basic premise: The interaction between cognitive and behavioral factors is the key mechanism involved in the perpetuation of insomnia. Essence of therapy: Cognitive-behavioral therapy for insomnia focuses on teaching techniques to modify sleep disruptive behaviors and cognitions that interfere with normal sleep and contribute to insomnia. Length : approx. 6 sessions Treatment Resources Editors: John Otis, PhD Note: The resources provided below are intended to supplement

Society of Clinical Psychology2014

44. Biofeedback-Based Treatments for Insomnia

Biofeedback-Based Treatments for Insomnia Biofeedback-Based Treatments for Insomnia | Society of Clinical Psychology Biofeedback-Based Treatments for Insomnia Status: Modest Research Support Description Biofeedback is a training technique that conveys information about a patients’ bodily functions that are typically considered outside conscious control. For instance, EMG biofeedback provides information about muscular activity. When treating insomnia, biofeedback is often used in conjunction (...) order) Morin, C., Bootzin, R., Buysse, D., Edinger, J., Espie, C., & Lichstein, K. (2006). Psychological and behavioral treatment of insomnia: Update of the recent evidence (1998-2004). Sleep , 29, 1398-1414. Barrowsky, E.I., Moskowitz, J., & Zweig, J.B. (1990). Biofeedback for disorders of initiating and maintaining sleep. Annals of the New York Academy of Sciences, 602 , 97-103. Sanavio, E., Vidotto, G., Bettinardi, O., Roletto, T., & Zorzi, M. (1990). Behavior therapy for DIMS: Comparison

Society of Clinical Psychology2014

45. Insomnia

Insomnia Insomnia - NICE CKS Clinical Knowledge Summaries Share Insomnia - Summary Insomnia is difficulty in getting to sleep, difficulty staying asleep, early wakening, or non-restorative sleep despite adequate time and opportunity to sleep, resulting in impaired daytime functioning, such as poor concentration, mood disturbance, and daytime tiredness. There is no standard definition of what constitutes normal sleep. It usually takes less than 30 minutes for a person to fall asleep. Average (...) total nocturnal sleep time decreases with age from about 8 hours at 15 years of age to less than 6 hours at 80 years of age. Insomnia can be categorized according to duration or likely duration: Short-term insomnia lasts less than 4 weeks. Long-term (or persistent) insomnia lasts for 4 weeks or longer. Sleep disorders that need to be excluded when making a diagnosis of insomnia are: Sleep apnoea — suspect in people with excessive daytime sleepiness and snoring and/or impaired concentration

NICE Clinical Knowledge Summaries2014

46. Belsomra (suvorexant) - To treat difficulty in falling and staying asleep (insomnia)

Belsomra (suvorexant) - To treat difficulty in falling and staying asleep (insomnia) Drug Approval Package: Brand Name (Generic Name) NDA # Drug Approval Package U.S. Food & Drug Administration Enter Search terms Drug Approval Package - Belsomra (suvorexant, MK-4305) Oral Tablets Company: Merck & Co., Inc. Application No.: 204569 Approval Date: 8/13/2014 Persons with disabilities having problems accessing the PDF files below may call (301) 796-3634 for assistance. (PDF) (PDF) (PDF) (PDF) (PDF

FDA - Drug Approval Package2014

49. Computerised cognitive behavioural therapy for insomnia: a systematic review and meta-analysis

Computerised cognitive behavioural therapy for insomnia: a systematic review and meta-analysis Computerised cognitive behavioural therapy for insomnia: a systematic review and meta-analysis Computerised cognitive behavioural therapy for insomnia: a systematic review and meta-analysis Cheng SK, Dizon J CRD summary This review concluded that computerised cognitive-behavioural therapy was a mildly to moderately effective over the short term for insomnia. The authors' conclusions should be treated (...) with caution given the uncertainties about the research methodologies. The recommendations for further research appear appropriate given the short-term nature of the included trials. Authors' objectives To evaluate the effectiveness of computerised cognitive-behavioural therapy for insomnia Searching The authors searched several databases (including MEDLINE, PsycINFO, EMBASE, CINAHL and The Cochrane Library) for studies published in English between 1990 and March 2011. Search terms were reported. Relevant

DARE.2013

50. Orexin receptor antagonism for treatment of insomnia: A randomized clinical trial of suvorexant

Orexin receptor antagonism for treatment of insomnia: A randomized clinical trial of suvorexant 23197752 2012 12 05 2013 02 04 2015 03 20 1526-632X 79 23 2012 Dec 04 Neurology Neurology Orexin receptor antagonism for treatment of insomnia: a randomized clinical trial of suvorexant. 2265-74 10.1212/WNL.0b013e31827688ee To assess the utility of orexin receptor antagonism as a novel approach to treating insomnia. We evaluated suvorexant, an orexin receptor antagonist, for treating patients (...) with primary insomnia in a randomized, double-blind, placebo-controlled, 2-period (4 weeks per period) crossover polysomnography study. Patients received suvorexant (10 mg [n = 62], 20 mg [n = 61], 40 mg [n = 59], or 80 mg [n = 61]) in one period and placebo (n = 249) in the other. Polysomnography was performed on night 1 and at the end of week 4 of each period. The coprimary efficacy end points were sleep efficiency on night 1 and end of week 4. Secondary end points were wake after sleep onset and latency

EvidenceUpdates2013

52. Meta-analytic review of the impact of cognitive-behavior therapy for insomnia on concomitant anxiety

Meta-analytic review of the impact of cognitive-behavior therapy for insomnia on concomitant anxiety Meta-analytic review of the impact of cognitive-behavior therapy for insomnia on concomitant anxiety Meta-analytic review of the impact of cognitive-behavior therapy for insomnia on concomitant anxiety Belleville G, Cousineau H, Levrier K, St-Pierre-Delorme ME CRD summary The review concluded that available data suggested that cognitive-behavioural therapy for insomnia had a positive moderate (...) impact on associated anxiety, but the magnitude of effects may be overestimated by the inclusion of findings from less rigorous studies. Potential for biases and the uncertain quality of the included studies limit the reliability of the pooled results. Authors' objectives To assess the impact of cognitive-behavioural therapy for insomnia (CBT-I) on associated anxiety. Searching MEDLINE, PsycINFO and ProQuest were searched between 1980 and 2009 for articles published in English or French. Search terms

DARE.2012

53. Chronic insomnia.

Chronic insomnia. Insomnia is a prevalent complaint in clinical practice that can present independently or comorbidly with another medical or psychiatric disorder. In either case, it might need treatment of its own. Of the different therapeutic options available, benzodiazepine-receptor agonists (BzRAs) and cognitive-behavioural therapy (CBT) are supported by the best empirical evidence. BzRAs are readily available and effective in the short-term management of insomnia, but evidence of long (...) -term efficacy is scarce and most hypnotic drugs are associated with potential adverse effects. CBT is an effective alternative for chronic insomnia. Although more time consuming than drug management, CBT produces sleep improvements that are sustained over time, and this therapy is accepted by patients. Although CBT is not readily available in most clinical settings, access and delivery can be made easier through use of innovative methods such as telephone consultations, group therapy, and self-help

Lancet2012

54. Comparative effectiveness of cognitive behavioral therapy for insomnia: a systematic review

Comparative effectiveness of cognitive behavioral therapy for insomnia: a systematic review Comparative effectiveness of cognitive behavioral therapy for insomnia: a systematic review Comparative effectiveness of cognitive behavioral therapy for insomnia: a systematic review Mitchell MD, Gehrman P, Perlis M, Umscheid CA CRD summary The review concluded that cognitive behavioural therapy was an effective treatment for insomnia that can produce durable results in a relatively small number (...) of visits. Given the small evidence base, unclear reporting of some results and limited quality, the authors' conclusions cannot be considered reliable Authors' objectives To evaluate the effectiveness of cognitive behavioural therapy (CBT) compared to medication in patients with primary and comorbid insomnia. Searching MEDLINE, EMBASE, Cochrane Central Register of Controlled Trials (CENTRAL) and PsycINFO were searched to September 2011 without language or publication restrictions. Search terms were

DARE.2012

55. The effect of melatonin, magnesium, and zinc on primary insomnia in long-term care facility residents in Italy: a double-blind, placebo-controlled clinical trial

The effect of melatonin, magnesium, and zinc on primary insomnia in long-term care facility residents in Italy: a double-blind, placebo-controlled clinical trial 21226679 2011 01 13 2011 02 18 2013 11 21 1532-5415 59 1 2011 Jan Journal of the American Geriatrics Society J Am Geriatr Soc The effect of melatonin, magnesium, and zinc on primary insomnia in long-term care facility residents in Italy: a double-blind, placebo-controlled clinical trial. 82-90 10.1111/j.1532-5415.2010.03232.x (...) To determine whether nightly administration of melatonin, magnesium, and zinc improves primary insomnia in long-term care facility residents. Double-blind, placebo-controlled clinical trial. One long-term care facility in Pavia, Italy. Forty-three participants with primary insomnia (22 in the supplemented group, 21 in the placebo group) aged 78.3 ± 3.9. Participants took a food supplement (5 mg melatonin, 225 mg magnesium, and 11.25 mg zinc, mixed with 100 g of pear pulp) or placebo (100 g pear pulp) every

EvidenceUpdates2011

56. Insomnia: treatment pathways, costs and quality of life

Insomnia: treatment pathways, costs and quality of life Insomnia: treatment pathways, costs and quality of life Insomnia: treatment pathways, costs and quality of life Scott GW, Scott HM, O'Keeffe KM, Gander PH Record Status This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study (...) and the conclusions drawn. CRD summary This study examined the cost-effectiveness of several treatments for insomnia in adults aged 20 to 59 years. The authors concluded that successful treatment for insomnia was highly cost-effective, despite conservative assumptions. Most of the data were from interviews with experts and the treatment pathways were not fully described, but the authors’ conclusions appear to be valid and robust. Type of economic evaluation Cost-utility analysis Study objective This study

NHS Economic Evaluation Database.2011

57. Effectiveness of acupressure for residents of long-term care facilities with insomnia: a randomized controlled trial

Effectiveness of acupressure for residents of long-term care facilities with insomnia: a randomized controlled trial 20056221 2010 05 24 2010 08 24 2015 11 19 1873-491X 47 7 2010 Jul International journal of nursing studies Int J Nurs Stud Effectiveness of acupressure for residents of long-term care facilities with insomnia: a randomized controlled trial. 798-805 10.1016/j.ijnurstu.2009.12.003 Acupressure on the Shenmen point (indexed as HT7) can improve insomnia, but there has been no (...) longitudinal study to evaluate its efficacy for residents of long-term care facilities. No evidence from the existing literature indicates how long its efficacy can be maintained after stopping acupressure. The aim of this study was to evaluate the effectiveness of acupressure on the Shenmen point for residents of long-term care facilities with insomnia. Fifty residents with insomnia in long-term care facilities were enrolled in a randomized controlled trial, with 25 participants allocated

EvidenceUpdates2010

58. Effectiveness of Valerian on insomnia: a meta-analysis of randomized placebo-controlled trials

Effectiveness of Valerian on insomnia: a meta-analysis of randomized placebo-controlled trials Effectiveness of Valerian on insomnia: a meta-analysis of randomized placebo-controlled trials Effectiveness of Valerian on insomnia: a meta-analysis of randomized placebo-controlled trials Fernandez-San-Martin MI, Masa-Font R, Palacios-Soler L, Sancho-Gomez P, Calbo-Caldentey C, Flores-Mateo G CRD summary The review concluded that the evidence suggested that valerian would be effective (...) for a subjective improvement for insomnia, although its effectiveness was not demonstrated with quantitative or objective measurements. The authors' cautious conclusions reflect the evidence presented and are likely to be reliable. Authors' objectives To evaluate the effectiveness of valerian ( Valeriana officinalis ) for the treatment of insomnia. Searching MEDLINE, the Cochrane Library, EMBASE and BIOSIS Previews were searched to September 2008 for published articles. No language restrictions were applied

DARE.2010

59. Cognitive behavioural therapy for insomnia in adults: a review of the clinical effectiveness

Cognitive behavioural therapy for insomnia in adults: a review of the clinical effectiveness Cognitive behavioural therapy for insomnia in adults: a review of the clinical effectiveness Cognitive behavioural therapy for insomnia in adults: a review of the clinical effectiveness Canadian Agency for Drugs and Technologies in Health Record Status This is a bibliographic record of a published health technology assessment from a member of INAHTA. No evaluation of the quality of this assessment has (...) been made for the HTA database. Citation Canadian Agency for Drugs and Technologies in Health. Cognitive behavioural therapy for insomnia in adults: a review of the clinical effectiveness. Ottawa: Canadian Agency for Drugs and Technologies in Health (CADTH). 2010 Authors' conclusions In the available literature, CBT seems to be effective in mediating the symptoms of primary insomnia as indicated by sleep outcome measures. The results demonstrate that CBT is as effective and in some studies even

Health Technology Assessment (HTA) Database.2010

60. Adding zolpidem to CBT produces limited benefits in persistent insomnia

Adding zolpidem to CBT produces limited benefits in persistent insomnia Adding zolpidem to CBT produces limited benefits in persistent insomnia | Evidence-Based Mental Health This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? Search for this keyword Search for this keyword Main menu Log in using your (...) username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here Adding zolpidem to CBT produces limited benefits in persistent insomnia Article Text Therapeutics Adding zolpidem to CBT produces limited benefits in persistent insomnia Statistics from Altmetric.com No Altmetric data available for this article. Question Question: Does the addition of zolpidem to cognitive behavioural therapy (CBT) improve persistent insomnia

Evidence-Based Mental Health2010